{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:06:28Z","timestamp":1769263588455,"version":"3.49.0"},"reference-count":10,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195021"],"award-info":[{"award-number":["1195021"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","award":["No grant numbers because this is a fund from a pha"],"award-info":[{"award-number":["No grant numbers because this is a fund from a pha"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","award":["No grant numbers because this is a fund from a pha"],"award-info":[{"award-number":["No grant numbers because this is a fund from a pha"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2025,6,20]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>The treatment of diabetic macular oedema (DMO) likely involves a series of treatment episodes separated by gaps during which no vascular endothelial growth factor inhibitor injections are delivered. Our aim is to differentiate the episodes and gaps with the isolation forests algorithm using the Fight Retinal Blindness! registry. We analysed 11\u2009786 injection intervals (12\u2009803 injections) and found that the period between adjacent injections\u226538 weeks (95% CI 34 to 43 weeks) apart could be regarded as a treatment gap. The results will allow treatment episodes to be isolated so that the treatment patterns of DMO can be characterised more accurately.<\/jats:p>","DOI":"10.1136\/bjo-2025-327238","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:45:23Z","timestamp":1751406323000},"page":"1279-1282","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Differentiating treatment episodes from gaps in eyes with diabetic macular oedema"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-6923","authenticated-orcid":false,"given":"Yohei","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-4679","authenticated-orcid":false,"given":"Adrian Robert","family":"Hunt","sequence":"additional","affiliation":[{"name":"Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Ophthalmology, Westmead Hospital, Westmead, New South Wales, Australia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-0833","authenticated-orcid":false,"given":"Rufino","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hospital of the University of Coimbra, Coimbra, Portugal"}]},{"given":"Antonella","family":"Witmer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, OLVG Hospital, Amsterdam, The Netherlands"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-3860","authenticated-orcid":false,"given":"Wajiha Jurdi","family":"Kheir","sequence":"additional","affiliation":[{"name":"Opthalmology, American University of Beirut Medical Center, Beirut, Lebanon"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1208-913X","authenticated-orcid":false,"given":"Francesco","family":"Viola","sequence":"additional","affiliation":[{"name":"Ophthalmology, Universita degli Studi di Milano, Milano, Italy"}]},{"given":"Maite","family":"Arrazola","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Basurto, Bilbao, Spain"}]},{"given":"Mohamed Moghazy","family":"Mahgoub","sequence":"additional","affiliation":[{"name":"Ain Shams University, Cairo, Egypt"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3902-239X","authenticated-orcid":false,"given":"Andreas","family":"Pollreisz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of Vienna, Vienna, Austria"}]},{"given":"Zanne","family":"Harvey","sequence":"additional","affiliation":[{"name":"Eyes Wide Bay, Hervey Bay, Queensland, Australia"}]},{"given":"Daniel","family":"Barthelmes","sequence":"additional","affiliation":[{"name":"Universitatsspital Zurich Augenklinik und Poliklinik, Zurich, Switzerland"}]},{"given":"Mark C","family":"Gillies","sequence":"additional","affiliation":[{"name":"Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia"}]}],"member":"239","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2026012223102369000_109.11.1279.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.03.021"},{"key":"2026012223102369000_109.11.1279.2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318296b271"},{"key":"2026012223102369000_109.11.1279.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.03.057"},{"key":"2026012223102369000_109.11.1279.4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety ofintravitreal faricimab with extended dosing up to every 16 weeks in patients withdiabetic macular oedema (YOSEMITE and RHINE): two randomised, doublemasked, phase 3 trial","volume":"399","author":"Wykoff","year":"2022","journal-title":"The Lancet"},{"key":"2026012223102369000_109.11.1279.5","first-page":"4647","article-title":"Clinical manifestations of syphilitic chorioretinitis: a retrospective study","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2026012223102369000_109.11.1279.6","doi-asserted-by":"publisher","DOI":"10.3390\/bdcc5010001"},{"key":"2026012223102369000_109.11.1279.7","doi-asserted-by":"publisher","DOI":"10.1145\/2382577.2382579"},{"key":"2026012223102369000_109.11.1279.8","doi-asserted-by":"publisher","DOI":"10.2307\/2289073"},{"key":"2026012223102369000_109.11.1279.9","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14746","article-title":"Treatment patterns and persistence rates with anti-vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real-world study","volume":"39","author":"Peto","year":"2022","journal-title":"Diabet Med"},{"key":"2026012223102369000_109.11.1279.10","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00750-9"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2025-327238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:11:00Z","timestamp":1769152260000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2025-327238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bjo-2025-327238"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2025-327238","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}